LC/MS-Based Untargeted Lipidomics Reveals Lipid Signatures of Sarcopenia
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25168793 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Qianwen Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Epidemiology and Statistics, School of Public Health, Lanzhou University, Lanzhou 730000, China. Hauptthemen laut MEDLINE: Sarcopenia, Lipidomics, Lipids, Lipid Metabolism. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Gansu Province Science Foundation for Youths.
Abstract (Originalsprache)
Sarcopenia, a multifactorial systemic disorder, has attracted extensive attention, yet its pathogenesis is not fully understood, partly due to limited research on the relationship between lipid metabolism abnormalities and sarcopenia. Lipidomics offers the possibility to explore this relationship. Our research utilized LC/MS-based nontargeted lipidomics to investigate the lipid profile changes as-sociated with sarcopenia, aiming to enhance understanding of its underlying mechanisms. The study included 40 sarcopenia patients and 40 control subjects matched 1:1 by sex and age. Plasma lipids were detected and quantified, with differential lipids identified through univariate and mul-tivariate statistical analyses. A weighted correlation network analysis (WGCNA) and MetaboAna-lyst were used to identify lipid modules related to the clinical traits of sarcopenia patients and to conduct pathway analysis, respectively. A total of 34 lipid subclasses and 1446 lipid molecules were detected. Orthogonal partial least squares discriminant analysis (OPLS-DA) identified 80 differen-tial lipid molecules, including 38 phospholipids. Network analysis revealed that the brown module (encompassing phosphatidylglycerol (PG) lipids) and the yellow module (containing phosphati-dylcholine (PC), phosphatidylserine (PS), and sphingomyelin (SM) lipids) were closely associated with the clinical traits such as maximum grip strength and skeletal muscle mass (SMI). Pathway analysis highlighted the potential role of the glycerophospholipid metabolic pathway in lipid me-tabolism within the context of sarcopenia. These findings suggest a correlation between sarcopenia and lipid metabolism disturbances, providing valuable insights into the disease’s underlying mechanisms and indicating potential avenues for further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Epidemiology and Statistics, School of Public Health, Lanzhou University, Lanzhou 730000, China.
ORCID-Profile: Lipeng Jing
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Gansu Province Science Foundation for Youths
Zitieren
APA
Yang, Q., Zhang, Z., He, P., Mao, X., Jing, X., Hu, Y., & Jing, L. (2024). LC/MS-Based Untargeted Lipidomics Reveals Lipid Signatures of Sarcopenia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25168793
Vancouver
Yang Q, Zhang Z, He P, Mao X, Jing X, Hu Y, et al. LC/MS-Based Untargeted Lipidomics Reveals Lipid Signatures of Sarcopenia. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25168793
BibTeX
@article{Yang2024,
author = {Yang, Qianwen and Zhang, Zhiwei and He, Panpan and Mao, Xueqian and Jing, Xueyi and Hu, Ying and Jing, Lipeng},
title = {LC/MS-Based Untargeted Lipidomics Reveals Lipid Signatures of Sarcopenia},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25168793}
}
EUVIMED